12:00 AM
 | 
Dec 11, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ME-609: Phase II

In a placebo-controlled North American Phase II trial of 380 treated patients with a history of sun-induced herpes simplex virus (HSV) infections around the mouth, ME-609...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >